United States Steel's Gloomy Outlook Sparks Analyst Drubbing

Macquarie downgraded X to "underperform" and cut its price target in half

by Lillian Currens

Published on Sep 19, 2019 at 10:06 AM

The shares of United States Steel Corporation (NYSE:X) gapped lower at the open today, and are now trading down 13.9% at $10.72, after the company late Wednesday updated its third-quarter forecast to a loss of 35 cents per share -- arriving well below the consensus estimate for a loss of 7 cents. The firm cited falling steel prices and deteriorating market conditions in Europe for its gloomy outlook. 

Macquarie downgraded X by a couple of notches to "underperform" from "outperform," and slashed its price target in half to $9, while Credit Suisse trimmed its target to $8 from $9. This adds to the already bleak analyst sentiment toward X; prior to today, only two analysts in coverage had given the security a "buy" or better rating, while the other nine call it a "hold" or "sell."

X is well on pace for its third consecutive daily decline -- a move catalyzed by its declining 100-day moving average. In fact, this isn't the first time the stock has sunk after a run up to the trendline, with two other rally attempts stopped by this ceiling in 2019. This trendline resistance has really done a number on X, considering its 64% year-over-year deficit. 

The stock has already been put on the short sale restricted (SSR) list for today, but the longer-term negative price action has been drawing out plenty of shorts in recent weeks. During the last two reporting periods, short interest on U.S. Steel rose 54.6%. The 51.73 million shares sold short make up a hefty 30.6% of the stock's available float, and represent 4.5 times X's average daily trading volume. 

 


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


3 Million to Lose Jobs – and Not Because of Coronavirus?
A terrifying new trend can make you a millionaire or destroy your financial future.
Dell Stock Jumps on Upbeat First Quarter
DELL announced an upbeat first-quarter report
Eli Lilly Stock Soars on FDA Approval
The FDA approved Eli Lilly's Alzheimer's disease diagnostic agent
Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.